Home > Drug Search >
  • Targets: Dihydrofolate reductase (DHFR)
  •   > 
Drug Filter
Status:
Approved (8) Withdrawn (1) NDA Filing (1) Phase Ⅱ (14) Phase Ⅰ (4)
Clinical Stage:
Pending (5) Active (6) Discontinued (8)
Company:
Endo (1) Genzyme (2) GlaxoSmithKline (1) Janssen (1) Lilly (1) Lundbeck (2) MedImmune (1) Merck Sharp & Dohme (1) Motif Bio (1) Orion (3) Dana-Farber Cancer Institute (1) Pfizer (1) Roche (2) Spectrum Pharmaceuticals (1) Takeda (1) Unknown (3) Youcare Pharmaceutical Group (1) Ash Stevens (1) Astex Pharmaceuticals (1) Quantum Genomic (1) Wilex (2) RedHill Biopharma (1) Link Health Group (1) Syntrix Biosystems (1) Angstrom (1) Ability Pharm (1) Antares Pharma (1) Turing Pharmaceuticals (1) Auspex (1) AstraZeneca (1) Chugai (1)
Indication:
Acute bacterial skin and skin structure infections (ABSSSI) (1) Acute lymphoblastic leukaemia (ALL) (3) Acute otitis media (1) Alzheimer's disease (AD) (2) Bladder cancer (1) Breast cancer (2) Chronic lymphocytic leukemia (CLL) (1) Colorectal neoplasms (1) Depression (1) Endometrial cancer (1) HIV infection (1) Hypertension (1) Lung cancer (1) Non small cell lung cancer (NSCLC) (2) Non-Hodgkin B-cell lymphomas (1) Osteosarcoma (1) Pancreatic cancer (1) Peripheral T cell lymphoma (PTCL) (1) Pleural mesothelioma (1) Pneumonia (3) Psoriasis (1) Rheumatoid arthritis (RA) (4) Schizophrenia (1) Solid tumours (2) Urinary tract infections (1) Pneumocystis pneumonia (1) Relapsed or refractory malignant lymphoma (1) Malaria (1) Kaposi's sarcoma (1) Bacterial infection (2)
Aprv. Year:
2004 (1) 2009 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top